vs
Axsome Therapeutics, Inc.（AXSM）与SPORTSMAN'S WAREHOUSE HOLDINGS, INC.（SPWH）财务数据对比。点击上方公司名可切换其他公司
SPORTSMAN'S WAREHOUSE HOLDINGS, INC.的季度营收约是Axsome Therapeutics, Inc.的1.7倍（$331.3M vs $191.2M），Axsome Therapeutics, Inc.同比增速更快（57.4% vs 2.2%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（48.1% vs -5.4%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
运动员仓库控股（Sportsman's Warehouse）是美国户外体育用品零售商，门店遍布全美29个州，主要面向狩猎、射击、露营、垂钓等各类户外休闲运动爱好者，销售户外服饰、鞋履及专业运动装备。
AXSM vs SPWH — 直观对比
营收规模更大
SPWH
是对方的1.7倍
$191.2M
营收增速更快
AXSM
高出55.2%
2.2%
两年增速更快
AXSM
近两年复合增速
-5.4%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $191.2M | $331.3M |
| 净利润 | — | $8.0K |
| 毛利率 | — | 32.8% |
| 营业利润率 | -33.1% | 1.3% |
| 净利率 | — | 0.0% |
| 营收同比 | 57.4% | 2.2% |
| 净利润同比 | — | -97.8% |
| 每股收益（稀释后） | — | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMSPWH
| Q1 26 | $191.2M | — | ||
| Q4 25 | $196.0M | $331.3M | ||
| Q3 25 | $171.0M | $293.9M | ||
| Q2 25 | $150.0M | $249.1M | ||
| Q1 25 | $121.5M | $340.4M | ||
| Q4 24 | $118.8M | $324.3M | ||
| Q3 24 | $104.8M | $288.7M | ||
| Q2 24 | $87.2M | $244.2M |
净利润AXSMSPWH
| Q1 26 | — | — | ||
| Q4 25 | $-28.6M | $8.0K | ||
| Q3 25 | $-47.2M | $-7.1M | ||
| Q2 25 | $-48.0M | $-21.3M | ||
| Q1 25 | $-59.4M | $-8.7M | ||
| Q4 24 | $-74.9M | $-364.0K | ||
| Q3 24 | $-64.6M | $-5.9M | ||
| Q2 24 | $-79.3M | $-18.1M |
毛利率AXSMSPWH
| Q1 26 | — | — | ||
| Q4 25 | — | 32.8% | ||
| Q3 25 | — | 32.0% | ||
| Q2 25 | — | 30.4% | ||
| Q1 25 | — | 30.4% | ||
| Q4 24 | — | 31.8% | ||
| Q3 24 | — | 31.2% | ||
| Q2 24 | — | 30.2% |
营业利润率AXSMSPWH
| Q1 26 | -33.1% | — | ||
| Q4 25 | -13.8% | 1.3% | ||
| Q3 25 | -27.0% | -1.1% | ||
| Q2 25 | -24.5% | -7.9% | ||
| Q1 25 | -46.9% | 1.1% | ||
| Q4 24 | -61.1% | 1.0% | ||
| Q3 24 | -59.8% | -1.5% | ||
| Q2 24 | -89.5% | -8.4% |
净利率AXSMSPWH
| Q1 26 | — | — | ||
| Q4 25 | -14.6% | 0.0% | ||
| Q3 25 | -27.6% | -2.4% | ||
| Q2 25 | -32.0% | -8.5% | ||
| Q1 25 | -48.9% | -2.6% | ||
| Q4 24 | -63.1% | -0.1% | ||
| Q3 24 | -61.7% | -2.0% | ||
| Q2 24 | -91.0% | -7.4% |
每股收益（稀释后）AXSMSPWH
| Q1 26 | — | — | ||
| Q4 25 | $-0.55 | $0.00 | ||
| Q3 25 | $-0.94 | $-0.18 | ||
| Q2 25 | $-0.97 | $-0.56 | ||
| Q1 25 | $-1.22 | $-0.22 | ||
| Q4 24 | $-1.54 | $-0.01 | ||
| Q3 24 | $-1.34 | $-0.16 | ||
| Q2 24 | $-1.67 | $-0.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $305.1M | $2.2M |
| 总债务越低越好 | $70.0M | $44.0M |
| 股东权益账面价值 | — | $209.5M |
| 总资产 | $713.6M | $913.9M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资AXSMSPWH
| Q1 26 | $305.1M | — | ||
| Q4 25 | $322.9M | $2.2M | ||
| Q3 25 | $325.3M | $1.8M | ||
| Q2 25 | $303.0M | $3.6M | ||
| Q1 25 | $300.9M | $2.8M | ||
| Q4 24 | $315.4M | $2.7M | ||
| Q3 24 | $327.3M | $2.6M | ||
| Q2 24 | $315.7M | $2.2M |
总债务AXSMSPWH
| Q1 26 | $70.0M | — | ||
| Q4 25 | — | $44.0M | ||
| Q3 25 | — | $43.9M | ||
| Q2 25 | — | $24.1M | ||
| Q1 25 | — | $24.1M | ||
| Q4 24 | — | $24.0M | ||
| Q3 24 | — | $24.0M | ||
| Q2 24 | — | — |
股东权益AXSMSPWH
| Q1 26 | — | — | ||
| Q4 25 | $88.3M | $209.5M | ||
| Q3 25 | $73.7M | $208.9M | ||
| Q2 25 | $73.1M | $215.1M | ||
| Q1 25 | $53.2M | $235.7M | ||
| Q4 24 | $57.0M | $243.6M | ||
| Q3 24 | $92.9M | $243.0M | ||
| Q2 24 | $102.9M | $247.5M |
总资产AXSMSPWH
| Q1 26 | $713.6M | — | ||
| Q4 25 | $689.8M | $913.9M | ||
| Q3 25 | $669.3M | $948.9M | ||
| Q2 25 | $639.8M | $929.7M | ||
| Q1 25 | $596.7M | $852.1M | ||
| Q4 24 | $568.5M | $967.7M | ||
| Q3 24 | $561.5M | $901.9M | ||
| Q2 24 | $548.2M | $930.4M |
负债/权益比AXSMSPWH
| Q1 26 | — | — | ||
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.10× | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $16.3M |
| 自由现金流经营现金流 - 资本支出 | — | $8.7M |
| 自由现金流率自由现金流/营收 | — | 2.6% |
| 资本支出强度资本支出/营收 | — | 2.3% |
| 现金转化率经营现金流/净利润 | — | 2038.00× |
| 过去12个月自由现金流最近4个季度 | — | $-39.7M |
8季度趋势，按日历期对齐
经营现金流AXSMSPWH
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $16.3M | ||
| Q3 25 | $1.0M | $-26.6M | ||
| Q2 25 | $-32.4M | $-60.2M | ||
| Q1 25 | $-43.4M | $52.8M | ||
| Q4 24 | $-26.2M | $-2.5M | ||
| Q3 24 | $-18.6M | $18.5M | ||
| Q2 24 | $-30.1M | $-34.6M |
自由现金流AXSMSPWH
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $8.7M | ||
| Q3 25 | $988.0K | $-33.9M | ||
| Q2 25 | $-32.4M | $-64.0M | ||
| Q1 25 | $-43.7M | $49.6M | ||
| Q4 24 | $-26.2M | $-6.2M | ||
| Q3 24 | $-18.7M | $14.1M | ||
| Q2 24 | $-30.2M | $-38.0M |
自由现金流率AXSMSPWH
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | 2.6% | ||
| Q3 25 | 0.6% | -11.5% | ||
| Q2 25 | -21.6% | -25.7% | ||
| Q1 25 | -36.0% | 14.6% | ||
| Q4 24 | -22.1% | -1.9% | ||
| Q3 24 | -17.9% | 4.9% | ||
| Q2 24 | -34.6% | -15.5% |
资本支出强度AXSMSPWH
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 2.3% | ||
| Q3 25 | 0.0% | 2.5% | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.3% | 1.0% | ||
| Q4 24 | 0.0% | 1.1% | ||
| Q3 24 | 0.1% | 1.5% | ||
| Q2 24 | 0.1% | 1.4% |
现金转化率AXSMSPWH
| Q1 26 | — | — | ||
| Q4 25 | — | 2038.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
SPWH
暂无分部数据
